Waters Cash on Hand 2011-2025 | WAT
Waters cash on hand from 2011 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Waters cash on hand for the quarter ending September 30, 2025 was $0.459B, a 38.51% increase year-over-year.
- Waters cash on hand for 2024 was $0.325B, a 17.83% decline from 2023.
- Waters cash on hand for 2023 was $0.396B, a 17.74% decline from 2022.
- Waters cash on hand for 2022 was $0.481B, a 15.44% decline from 2021.
|
Waters Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $325 |
| 2023 | $396 |
| 2022 | $481 |
| 2021 | $569 |
| 2020 | $443 |
| 2019 | $337 |
| 2018 | $1,735 |
| 2017 | $3,394 |
| 2016 | $2,813 |
| 2015 | $2,399 |
| 2014 | $2,055 |
| 2013 | $1,804 |
| 2012 | $1,539 |
| 2011 | $1,281 |
| 2010 | $946 |
|
Waters Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-09-30 | $459 |
| 2025-06-30 | $367 |
| 2025-03-31 | $383 |
| 2024-12-31 | $325 |
| 2024-09-30 | $331 |
| 2024-06-30 | $327 |
| 2024-03-31 | $338 |
| 2023-12-31 | $396 |
| 2023-09-30 | $337 |
| 2023-06-30 | $331 |
| 2023-03-31 | $487 |
| 2022-12-31 | $481 |
| 2022-09-30 | $445 |
| 2022-06-30 | $420 |
| 2022-03-31 | $503 |
| 2021-12-31 | $569 |
| 2021-09-30 | $655 |
| 2021-06-30 | $664 |
| 2021-03-31 | $810 |
| 2020-12-31 | $443 |
| 2020-09-30 | $397 |
| 2020-06-30 | $356 |
| 2020-03-31 | $394 |
| 2019-12-31 | $337 |
| 2019-09-30 | $405 |
| 2019-06-30 | $676 |
| 2019-03-31 | $1,167 |
| 2018-12-31 | $1,735 |
| 2018-09-30 | $2,084 |
| 2018-06-30 | $2,248 |
| 2018-03-31 | $2,552 |
| 2017-12-31 | $3,394 |
| 2017-09-30 | $3,255 |
| 2017-06-30 | $3,126 |
| 2017-03-31 | $2,966 |
| 2016-12-31 | $2,813 |
| 2016-09-30 | $2,713 |
| 2016-06-30 | $2,600 |
| 2016-03-31 | $2,505 |
| 2015-12-31 | $2,399 |
| 2015-09-30 | $2,311 |
| 2015-06-30 | $2,209 |
| 2015-03-31 | $2,109 |
| 2014-12-31 | $2,055 |
| 2014-09-30 | $1,946 |
| 2014-06-30 | $1,918 |
| 2014-03-31 | $1,853 |
| 2013-12-31 | $1,804 |
| 2013-09-30 | $1,699 |
| 2013-06-30 | $1,650 |
| 2013-03-31 | $1,590 |
| 2012-12-31 | $1,539 |
| 2012-09-30 | $1,448 |
| 2012-06-30 | $1,392 |
| 2012-03-31 | $1,354 |
| 2011-12-31 | $1,281 |
| 2011-09-30 | $1,194 |
| 2011-06-30 | $1,122 |
| 2011-03-31 | $1,039 |
| 2010-12-31 | $946 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.145B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $213.267B | 25.34 |
| Intuitive Surgical (ISRG) | United States | $196.642B | 76.93 |
| IDEXX Laboratories (IDXX) | United States | $57.510B | 57.11 |
| Edwards Lifesciences (EW) | United States | $48.635B | 32.23 |
| Alcon (ALC) | Switzerland | $36.668B | 24.62 |
| IQVIA Holdings (IQV) | United States | $35.783B | 19.95 |
| Mettler-Toledo (MTD) | United States | $29.657B | 35.20 |
| STERIS (STE) | Ireland | $23.951B | 24.64 |
| DexCom (DXCM) | United States | $23.120B | 31.87 |
| Hologic (HOLX) | United States | $16.510B | 17.38 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.063B | 0.00 |
| Penumbra (PEN) | United States | $8.796B | 62.13 |
| Globus Medical (GMED) | United States | $8.307B | 19.16 |
| Masimo (MASI) | United States | $7.635B | 24.47 |
| Sysmex ADR (SSMXY) | Japan | $6.484B | 20.60 |
| Teleflex (TFX) | United States | $5.513B | 8.90 |
| Glaukos (GKOS) | United States | $4.845B | 0.00 |
| TransMedics (TMDX) | United States | $4.253B | 50.39 |
| Veracyte (VCYT) | United States | $3.622B | 41.48 |
| Alphatec Holdings (ATEC) | United States | $2.929B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.774B | 14.99 |
| Integer Holdings (ITGR) | United States | $2.388B | 11.21 |
| Artivion (AORT) | United States | $2.195B | 110.74 |
| Nihon Kohden (NHNKY) | Japan | $1.980B | 23.63 |
| PROCEPT BioRobotics (PRCT) | United States | $1.759B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.736B | 16.82 |
| Beta Bionics (BBNX) | United States | $1.167B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.095B | 0.00 |
| IRadimed (IRMD) | United States | $1.081B | 51.49 |
| AxoGen (AXGN) | United States | $1.078B | 0.00 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.991B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.888B | 4.81 |
| SiBone (SIBN) | United States | $0.663B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.591B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.575B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.541B | 31.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.495B | 9.87 |
| AngioDynamics (ANGO) | United States | $0.491B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.483B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.435B | 3.42 |
| NeuroPace (NPCE) | United States | $0.432B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.411B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.408B | 10.38 |
| Treace Medical Concepts (TMCI) | United States | $0.395B | 0.00 |
| RxSight (RXST) | United States | $0.341B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.336B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.307B | 51.06 |
| Spectral Diagnostics (EDTXF) | Canada | $0.292B | 0.00 |
| 908 Devices (MASS) | United States | $0.290B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.263B | 0.00 |
| CVRx (CVRX) | United States | $0.256B | 0.00 |
| Inogen (INGN) | United States | $0.200B | 0.00 |
| Neuronetics (STIM) | United States | $0.188B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.145B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.142B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Hyperfine (HYPR) | United States | $0.089B | 0.00 |
| InspireMD (NSPR) | United States | $0.088B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.080B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.079B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.061B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.66 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |